Abstract:Vaccination is the most effective method for the prevention of COVID-19 caused by SARS-CoV-2, which is still a global epidemic. However, the evolution of SARS-CoV-2 is so rapid that various variants, including the Alpha, Beta, Gamma, Delta, and Omicron variants, have emerged, lowering the protection rate of vaccines and even resulting in breakthrough infections. Additionally, some rare but severe adverse reactions induced by COVID-19 vaccines may raise safety concerns and hinder vaccine promotion; however, clinical studies have shown that the benefits of vaccination outweigh the risks caused by adverse reactions. Current vaccines approved with emergency use authorization (EUA) were originally adaptive for adults only, and infants, children, and adolescents are not included. New-generation vaccines are needed to overcome the challenges of limited adaptive age population, breakthrough infection (mainly due to virus variant emergencies), and critical adverse reactions. Fortunately, some advances in COVID-19 vaccines have been obtained regarding enlarged adaptive populations for clinical applications, such as the Pfizer/BioNTech vaccine and the Moderna vaccine. In this article, we provide a review on the challenges and recent advancements in COVID-19 vaccines. The development of next-generation COVID-19 vaccines should lay emphasis on the expansion of adaptive age populations in all individuals, the induction of immune responses to viral variants, the avoidance or alleviation of rare but potentially critical adverse reactions, and the discovery of subunit vaccines with adjuvants encapsulated in nanoparticles.

Challenges in the Development of a Vaccine Against COVID-19

SARS-CoV-2 Vaccine Development and Challenges

Coronavirus vaccine development: from SARS and MERS to COVID-19

Efforts at COVID-19 Vaccine Development: Challenges and Successes

SARS-CoV-2: Mapping its features that made it as a unique virus

The COVID-19 Vaccines: Recent Development, Challenges and Prospects

Development of SARS-CoV-2 Vaccine: Challenges and Prospects

Challenges and prospects of COVID-19 vaccine development based on the progress made in SARS and MERS vaccine development

Challenges and Progress in Vaccine Development for COVID-19 Coronavirus (SARS-CoV-2): A Review

Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects

Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19)

SARS-CoV-2: vaccines in the pandemic era

The way of SARS-CoV-2 vaccine development: success and challenges

mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2

COVID-19: Coronavirus Vaccine Development Updates

Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines

Research progress and challenges to coronavirus vaccine development

Development of SARS-CoV-2 vaccines

COVID-19 vaccine: where are we now and where should we go?

Challenges and Recent Advancements in COVID-19 Vaccines

Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection